Metsera Inc. (MTSR), a New York-based biotech that went public on Jan. 31 with some fanfare, has a full portfolio of weight-loss drugs in development, using both the hormones already used in existing ...
Nvidia Corp.’s stock still looks good to many Wall Street analysts ahead of the artificial-intelligence chip maker’s earnings ...
Nvidia (NASDAQ:NVDA) is once again at the center of Wall Street's attention as analysts set the stage for another strong ...
Evercore ISI says the firm would be buyers of Nvidia (NVDA) into the company’s January quarter earnings call scheduled for February 26. While ...
Evercore (NYSE: EVR) will host its 2nd annual Private Markets Forum in New York City on March 11-12, 2025. This year’s event will host executives and industry experts from over 20 leading private ...
Nvidia (NVDA) was in focus on Tuesday as investment firms Evercore ISI and Piper Sandler issued positive notes on the ...
Evercore ISI analyst Kutgun Maral reiterated a Buy rating on Liberty Media Liberty Formula One (FWONK – Research Report) yesterday and set a ...
Trump directed a US agency to limit Chinese spending on technology and other strategic US sectors. Read more at ...
20hon MSN
Julian Emanuel, Evercore ISI senior managing director, joins 'Fast Money' to talk the impact of tariffs, uncertainty, and ...
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be ...
Investing.com-- Evercore analysts expect a sizable revenue bump from Apple Inc's (NASDAQ: AAPL) recently unveiled iPhone 16e ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results